These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1900059)

  • 21. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.
    Kink JA; Williams JA
    Infect Immun; 1998 May; 66(5):2018-25. PubMed ID: 9573084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.
    Mahe S; Corthier G; Dubos F
    Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody-mediated neutralization of Clostridioides difficile toxin does not diminish induction of the protective innate immune response to infection.
    Denny JE; Alam MZ; Mdluli NV; Maslanka JR; Lieberman LA; Abt MC
    Anaerobe; 2024 Aug; 88():102859. PubMed ID: 38701911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
    Hong HA; Hitri K; Hosseini S; Kotowicz N; Bryan D; Mawas F; Wilkinson AJ; van Broekhoven A; Kearsey J; Cutting SM
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of Clostridium difficile toxin A using antibody combinations.
    Demarest SJ; Hariharan M; Elia M; Salbato J; Jin P; Bird C; Short JM; Kimmel BE; Dudley M; Woodnutt G; Hansen G
    MAbs; 2010; 2(2):190-8. PubMed ID: 20150758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
    Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
    J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.
    Amadou Amani S; Lang GA; Ballard JD; Lang ML
    Infect Immun; 2021 Sep; 89(10):e0027421. PubMed ID: 34097471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
    Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
    J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
    Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J
    J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM; Phelps CJ; Wilkins TD
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
    Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
    J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.
    Gardiner DF; Rosenberg T; Zaharatos J; Franco D; Ho DD
    Vaccine; 2009 Jun; 27(27):3598-604. PubMed ID: 19464540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.
    Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S
    PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.
    Anosova NG; Cole LE; Li L; Zhang J; Brown AM; Mundle S; Zhang J; Ray S; Ma F; Garrone P; Bertraminelli N; Kleanthous H; Anderson SF
    Clin Vaccine Immunol; 2015 Jul; 22(7):711-25. PubMed ID: 25924765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Chimeric Protein Vaccines Against
    Wang S; Wang Y; Cai Y; Kelly CP; Sun X
    Front Immunol; 2018; 9():2440. PubMed ID: 30405630
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
    Fu SW; Zhou DY; Lai ZS; Xue J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF; Monath TP
    J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an ELISA kit using monoclonal antibody to Clostridium difficile toxin A.
    Fu SW; Zhang YL; Zhou DY
    World J Gastroenterol; 2004 Sep; 10(18):2747-9. PubMed ID: 15309733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.
    Müller F; Stiegler C; Hadding U
    J Clin Microbiol; 1992 Jun; 30(6):1544-50. PubMed ID: 1378062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.
    Aboudola S; Kotloff KL; Kyne L; Warny M; Kelly EC; Sougioultzis S; Giannasca PJ; Monath TP; Kelly CP
    Infect Immun; 2003 Mar; 71(3):1608-10. PubMed ID: 12595488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.